Asset type Domestic Equity Sector

KODEX Healthcare(266420)

KODEX Healthcare ETF invests in KRX Healthcare Sector which represents the leading companies in Healthcare industry sector covering KOSPI and KOSDAQ market.

  • Current Price
    (KRW)

    10,820

  • iNAV
    (KRW)

    10,941

    down 323 (-2.87%)

  • Trading Volume
    (shares)

    7,111

* Last data obtained
Quotes delayed at least 20 minutes.Market data provided by KOSCOM.

*as of

Benchmark Index

KRX Healthcare

The KRX Autos Index is designed to track the performance of the Healthcare sector. Leading companies within the sector are chosen from a pool of both KOSPI- and KOSDAQ-listed stocks based on various standards such as market capitalization and liquidity.

View index information in detail
Key Facts
  • Net Assets
    24 (billion)
  • Inception Date
    March 28, 2017
  • Gross Expense
    Ratio
    0.090%
    (AP : 0.005%, Manager fee : 0.065%, Trustee Fee : 0.010%, General Administrator Fee : 0.010%)
  • Dividend
    Quarterly and the last Business Day of fiscal year dividend distribution, only if applicable.
    (Record date : last Business Day of January, April, July, and October, and fiscal year)
  • Base Currency
    KRW
  • General
    Administrator
    KSD
  • Trustee
    KEB Hana Bank
  • Related
    Documents
    -
  • Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing.
  • Collective investment schemes are not insured by the Korea Deposit Insurance Corporation.
  • The performance quoted represents past performance and does not guarantee future results.
  • Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold.
  • Current performance may be lower or higher than the performance quoted.
  • This information is not warranted to be accurate, complete, or timely.
  • Neither KOSCOM nor Samsung Asset Management is responsible for any damages or losses arising from any use of the information on this website.
  • This website is made in the Korean language, and if there shall arise any conflict between the Korean version and any translation thereof, including this -English translation, the Korean version shall prevail.